|
Decades of underpowered RCT
|
|
9
|
141
|
July 7, 2025
|
|
The Petty/Bone RCT
|
|
103
|
6983
|
June 25, 2025
|
|
Randomized non-comparative trials: an oxymoron?
|
|
50
|
3464
|
June 3, 2025
|
|
Why the Non-Reproducibility of Acute Care RCT? The CAP studies
|
|
6
|
150
|
May 8, 2025
|
|
Use of conditional estimands in regulatory settings
|
|
2
|
81
|
April 29, 2025
|
|
Factorial trial with interest in individual contrasts
|
|
1
|
27
|
April 26, 2025
|
|
CONSORT 2025 RCT standards document
|
|
2
|
140
|
April 25, 2025
|
|
A randomized withdrawal design
|
|
0
|
43
|
April 24, 2025
|
|
Covariate Balancing in post-hoc analysis
|
|
5
|
86
|
April 24, 2025
|
|
Missing data in repeated measures
|
|
7
|
713
|
April 15, 2025
|
|
Dichotomization
|
|
69
|
3128
|
March 24, 2025
|
|
Causal inferences from RCTs- could “toy” clinical examples promote understanding?
|
|
15
|
1912
|
February 3, 2025
|
|
Alpha spending/information fraction when controlling for baseline covariate
|
|
2
|
580
|
January 29, 2025
|
|
Confusion flows downhill- a plea to methods teachers for unified messaging
|
|
39
|
1842
|
January 10, 2025
|
|
Non Inferiority vs Non significant
|
|
17
|
1548
|
December 19, 2024
|
|
What is a fake measurement tool and how are they used in RCT
|
|
53
|
20524
|
December 10, 2024
|
|
Evaluating treatment response predictive models separately per treatment arm
|
|
5
|
735
|
December 10, 2024
|
|
RWE: use of target trial emulation framework: why aiming to emulate RCT?
|
|
4
|
1002
|
December 3, 2024
|
|
Analyzing compositional outcome data
|
|
6
|
3990
|
November 22, 2024
|
|
Presenting data for extremely small n size clinical trials
|
|
2
|
776
|
October 27, 2024
|
|
Prior design in a bayesian re-analysis of an RCT
|
|
4
|
1121
|
October 20, 2024
|
|
Individual response
|
|
247
|
47314
|
August 21, 2024
|
|
Use of percentage change in clinical trials
|
|
17
|
8996
|
July 22, 2024
|
|
ITT analysis under equally high non-adherence in both arms in RCT
|
|
4
|
1043
|
June 9, 2024
|
|
Run-in phase in RCTs
|
|
14
|
10449
|
April 1, 2024
|
|
Communicating statistical concerns to the FDA
|
|
3
|
1336
|
March 11, 2024
|
|
Is Lithium Equivalent to Lecanemab in Slowing cognitive decline in Alzheimer's Disease?
|
|
0
|
1115
|
February 23, 2024
|
|
Assessing correlation/surrogacy between 2 estimated treatment effects
|
|
9
|
1904
|
February 17, 2024
|
|
Review of Trial at the Center of the Firestorm Over Early Connection of Patients to Ventilators during the Pandemic
|
|
34
|
5537
|
February 16, 2024
|
|
RCT: protocol deviation and implications for analysis
|
|
6
|
1291
|
February 16, 2024
|